Program Thursday, May 25

Mixiii Biomed 2017 Conference Program has nine main tracks consisting of invited Lectures/Panels and company presentations.

Trending topics have been identified and through this focused track approach, participants have the opportunity to gain a deeper understanding and more insight into the subjects.

Please note:
Time slots highlighted in light blue indicate company presentations.

Please check program on site in case of last minute changes.



THURSDAY, MAY 25, 2017
08:30 – 15:00	Registration Open
09:00 - 09:20	Aharon Aharon, ‎CEO Israel Innovation Authority
09:20 - 10:00	Prof. Nir Barzilai, MD, Albert Einstein College of Medicine: "The genetic underline of exceptional longevity–drug development"
10:00 – 10:40	Lloyd Klickstein MD, PhD, Head of Translational Medicine, New Indications Discovery Unit at Novartis Institutes for BioMedical Research, Novartis: "The Promise of New Approaches for Aging"
10:40 - 11:15	Prof. Junxia Min, MD, PhD, Zhejiang University, China: "Challenges and promises of aging trajectory in China"
11:15 – 11:35	Coffee Break
11:35 - 13:40	AGE RELATED DISEASES HALL A
	CARDIOLOGY
	Cardiology Chairperson: Prof. Amir Lerman, MD, Mayo Clinic
11:35 - 11:55	Prof. Amir Lerman, MD, Mayo Clinic: "Opportunities in cardiovascular aging"
11:55 - 12:15	Prof. Haim Danenberg, MD, Hadassah Medical Center: "The revolution and evolution of transcatheter therapy of structural heart disease"
12:15 - 12:30	Daniel Weiss, Enopace Biomedical: "Aortic Stimulation for Neuromodulation of Heart Failure"
12:30- 12:50	Prof. Rafi Beyar, MD, PhD, Rambam Medical Center: "Robots getting into your heart"
	OPHTHALMOLOGY
12:50 - 13:10	Prof. Anat Loewenstein, MD, Tel Aviv Medical Center: "Diagnosis and Treatment of Age Related Macular Degeneration (AMD) in 2017 and Beyond"
13:10 - 13:25	Yaakov Milstain, Nano Retina: "BioRetina"
13:25 - 13:40	Nahum Ferera, EyeYon Medical: "Innovative solutions for corneal healing"
13:40 - 14:55	Lunch Break
	ONCOLOGY
14:55 -15:25	Rachel W. Humphrey, MD, SVP, Chief Medical Officer, CytomX Therapeutics: "New Frontiers in Immuno-oncology Treatments - Challenges and Opportunities"
15:25 - 15:45	Prof. Dror Harats, MD, CEO, VBL Therapeutics: "Viral Immune Oncology"
15:45 - 16:00	Tsipi Keren-Lehrer, Compugen: "From Code to Cure: Predictive Discovery of Novel Immune Checkpoints"
16:00 - 16:15	David Malek, BioLineRx: "BioLineRx developing novel treatments which could improve the activity of cancer immunotherapy"
16:15 - 16:30	Oren M. Becker, ViDAC Pharma: "Novel metabolic immuno-oncology drugs for skin cancer and solid tumors"
16:30 - 16:45	Offer Fabian, Musli Thyropeutics Ltd.: "Cancer and thyroid - a novel Oncological approach"
16:45 - 17:45	Panel: Discussion & Conclusion

THURSDAY, MAY 25, 2017
08:30 – 15:00	Registration Open
09:00 - 09:20	Aharon Aharon, ‎CEO Israel Innovation Authority
09:20 - 10:00	Prof. Nir Barzilai, MD, Albert Einstein College of Medicine: "The genetic underline of exceptional longevity–drug development"
10:00 – 10:40	Lloyd Klickstein MD, PhD, Head of Translational Medicine, New Indications Discovery Unit at Novartis Institutes for BioMedical Research, Novartis: "The Promise of New Approaches for Aging"
10:40 - 11:15	Prof. Junxia Min, MD, PhD, Zhejiang University, China: "Challenges and promises of aging trajectory in China"
11:15 – 11:35	Coffee Break
11:35 - 16:45	LONGEVITY: GENETICS AND EPIGENETICS HALL B
	Symposium Chairperson: Prof. Nir Barzilai, MD, Albert Einstein College of Medicine:
11:35 - 11:55	Prof. Nir Barzilai, MD, Albert Einstein College of Medicine:
11:55 - 12:10	Natalie Yivgi Ohana, Minovia Therapeutics: "Mitochondrial Therapy and Age-Related Diseases"
12:10 - 12:25	Yona Keisari, Alpha Tau Medical LTD.: "Alpha DaRT: A Novel Effective and Safe Alpha Radiation Based Radiotherapy"
12:25 - 12:40	Ilia Stambler, Comorbidity Detection Technologies - CD Technologies Ltd: "The Quantified Longevity Guide - QLG"
12:40 - 13:10	Prof. Steven N. Austad, PhD, University of Alabama: "Aging has a biology that can be targeted!- pre clinical data and repurposing of drugs"
13:10 - 13:40	Prof. James L Kirkland, MD, PhD, Mayo Clinic: "Targeting Senescent Cells: The Path to Translation"
13:40 - 14:55	Lunch Break
14:55 - 15:15	Prof. Haim Cohen, PhD, Bar-Ilan University: "Moses: A mouse model for health and longevity-drug development (Sirt6-Moses)"
15:15 - 15:30	Boaz Brill, GluSense Ltd.: "GluSense Glyde CGM - a long-term implantable glucose sensor"
15:30 - 15:45	Lihi Segal, DayTwo: "Balancing Blood Glucose Levels using Gut Microbiome"
15:45 - 16:00	Yael Glassman, Nutrino Health Ltd.: "Personalized Nutrition in Diabetes - Food as Medicine"
16:00 - 16:15	Nadav Kidron, Oramed Pharmaceuticals: "Oramed Pharmaceuticals: Oral insulin and the future of diabetes care"
16:15 - 17:00	Panel: Discussion & Conclusion Moderator: Prof. Nir Barzilai, MD, Albert Einstein College of Medicine

THURSDAY, MAY 25, 2017
08:30 – 15:00	Registration Open
09:00 - 09:20	Aharon Aharon, ‎CEO Israel Innovation Authority
09:20 - 10:00	Prof. Nir Barzilai, MD, Albert Einstein College of Medicine: "The genetic underline of exceptional longevity–drug development"
10:00 – 10:40	Lloyd Klickstein MD, PhD, Head of Translational Medicine, New Indications Discovery Unit at Novartis Institutes for BioMedical Research, Novartis: "The Promise of New Approaches for Aging"
10:40 - 11:15	Prof. Junxia Min, MD, PhD, Zhejiang University, China: "Challenges and promises of aging trajectory in China"
11:15 – 11:35	Coffee Break
11:35 - 17:00	TTO: WORK IN PROCESS IN THE ACADEMIA HALL C
	Symposium Chairperson: Gil Granot-Mayer, Yeda Research & Development Co. Ltd.
11:35 - 11:45	Gil Granot-Mayer, Yeda Research & Development Co. Ltd. "Introduction"
11:45 - 12:00	Dr. Eyal Zimlichman, Sheba Medical Center Hospital: “Big data and digital health solutions for aging related issues”
12:00 - 12:15	Prof. Tamir Ben Hur, Hadassah Jerusalem Medical Center: "A clinical and translational view of Alzheimer’s disease therapeutics"
12:15 - 12:30	Prof. Michal Schwartz, Weizmann Institute: "The potential of immune checkpoint blockade for fighting against Alzheimer's disease"
12:30 - 12:45	Prof. Valery Krizhanovsky, Weizmann Institute: “Directed elimination of senescent cells for targeting of age-related diseases”
12:45 - 13:00	Prof. Ehud Cohen, The Hebrew University of Jerusalem: "From a single disease to a complex syndrome – the challenge of Alzheimer’s disease and novel research strategies"
13:00 - 13:15	Prof. Tal Dvir, Tel-Aviv University: "Engineering Organs and Body Parts"
13:15 - 13:40	Questions and Answers
13:40 - 14:55	Lunch Break
	TTO: COMPANIES FROM THE ACADEMIA HALL C
	Moderator: Dr. Shay Sela, Yeda Research & Development Co. Ltd.
14:55 - 15:15	Dr. Andy Levy, BioRap Technologies LTD: “Prediction and Prevention of Diabetes-Related Complications- from academia to market”
15:15 - 15:30	Dr. Arnon Karni, Tel Aviv Mecical Center "Induction of repair by oligodendrogenesis and neurogenesis in immune mediated diseases of central nervous system"
15:30 - 15:45	Dr. Jonathan Solomon, NeuroPhage Pharmaceutical: "ProClara / NeuroPhage - A singular approach to protein misfolding diseases"
15:45 - 16:00	Mr. Moshe Weinstein, Moebius Medical Ltd.: “A novel and sustainable pain relief treatment for osteoarthritis”
16:00 - 16:15	Dr. Eti Yoles, Immunobrain Checkpoint Ltd.: “Treatment of Alzheimer's disease”
16:15 - 16:30	Mr. Eyal Gura, Zebra Technologies: “Early detection of Osteoporosis”
16:30 - 16:45	Prof. Zeev Zalevsky, ContinUse Biometrics Ltd.: “Remote & contactless bio-sensing”
16:45 - 17:00	Dr. Edi Barkai, Memoboost Ltd.: "Drug Development for Cognitive Enhancement"